It is a pharma public limited company based in Urban Estate, Haryana, India, established in 2011.
2011 | Urban Estate, Haryana, India | ActiveVaxer Pharma Limited, a active public limited company, was established on 30 August 2011 in Urban Estate, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999HR2011PLC122348. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹0.55 M.
It upholds a compliant status. Employing 5 professional, Its leadership includes Bodh Raj Sikri (Director), Pochiraju Hanumath Subba Rao (Director), Anshul Sikri (Director). Past directors included Bodh Raj Sikri, Suman Malhotra, Rohit Reddy Penaka. It holds ₹15.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Second Floor, Sco-313, Sector-29, Urban Estate, Haryana, 122001.
U74999HR2011PLC122348
122348
30 August 2011
₹5.00 Cr
₹0.55 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Vaxer Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bodh Raj Sikri | Director | 16 Jan 2014 | Current |
| Pochiraju Hanumath Subba Rao | Director | 30 Aug 2011 | Current |
| Anshul Sikri | Director | 30 Aug 2011 | Current |
| Suman Malhotra | Director | 27 Mar 2021 | Current |
| Aastha Dewan | Director | 27 Mar 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 16 Jan 2014 | Past |
| Pramod Abcsdd | Director | 16 Jan 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vaxer Pharma Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.44% increase. The company also saw a substantial fall in profitability, with a 57.88% decrease in profit. The company's net worth moved up by a moderate rise of 6.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Vaxer Pharma had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹150,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2022 | Yes Bank Limited | ₹15.00 Cr | Open |
Explore comprehensive loan charge details -
Vaxer Pharma has a workforce of 5 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vaxer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaxer Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Vaxer Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Vaxer Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge with Yes Bank Limited amounted to Rs. 15.00 Cr with Charge ID 100667833 was registered on 28 Dec 2022. was completed.
Progress on Suman Malhotra was appointed as a Director was appointed as a Director on 27 Mar 2021 & has been associated with this company since 4 years 8 months . was documented.
The activity Aastha Dewan was appointed as a Director was appointed as a Director on 27 Mar 2021 & has been associated with this company since 4 years 8 months . was completed.
Progress on Bodh Raj Sikri was appointed as a Director was appointed as a Director on 16 Jan 2014 & has been associated with this company since 11 years 10 months . was documented.
The CIN of Vaxer Pharma Limited is U74999HR2011PLC122348.
Vaxer Pharma Limited is headquartered at Second Floor, Sco-313, Sector-29, Urban Estate, Haryana, 122001.
Vaxer Pharma Limited was incorporated on 30 August 2011.
The current directors of Vaxer Pharma Limited are
The primary industry of Vaxer Pharma Limited is Trade.
Vaxer Pharma Limited is unlisted.
The authorized capital of Vaxer Pharma Limited is ₹5.00 Cr, and the paid-up capital is ₹0.55 M.
The compliance status of Vaxer Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX